FY2027 Earnings Forecast for Denali Therapeutics Inc. (NASDAQ:DNLI) Issued By HC Wainwright
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Equities research analysts at HC Wainwright upped their FY2027 EPS estimates for shares of Denali Therapeutics in a research report issued on Wednesday, May 8th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings of $1.99 per share for the year, up from […]
More Stories
Viavi Solutions Inc. (NASDAQ:VIAV) Shares Sold by Hsbc Holdings PLC
Hsbc Holdings PLC cut its stake in shares of Viavi Solutions Inc. (NASDAQ:VIAV – Free Report) by 11.4% in the...
Price T Rowe Associates Inc. MD Increases Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Price T Rowe Associates Inc. MD boosted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 8.1%...
The Goldman Sachs Group Cuts Arista Networks (NYSE:ANET) Price Target to $115.00
Arista Networks (NYSE:ANET – Free Report) had its price objective lowered by The Goldman Sachs Group from $130.00 to $115.00...
Price T Rowe Associates Inc. MD Purchases 1,902 Shares of CTS Co. (NYSE:CTS)
Price T Rowe Associates Inc. MD grew its holdings in shares of CTS Co. (NYSE:CTS – Free Report) by 7.6%...
B. Riley Estimates Celsius’ Q3 Earnings (NASDAQ:CELH)
Celsius Holdings, Inc. (NASDAQ:CELH – Free Report) – Equities research analysts at B. Riley raised their Q3 2025 earnings per...
Corbus Pharmaceuticals (NASDAQ:CRBP) Given New $56.00 Price Target at Oppenheimer
Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) had its target price reduced by Oppenheimer from $60.00 to $56.00 in a research...